Skip to main content
Biofilm logoLink to Biofilm
. 2021 Dec 9;4:100063. doi: 10.1016/j.bioflm.2021.100063

The role of biofilm formation in the pathogenesis and antimicrobial susceptibility of Cutibacteriumacnes

Tom Coenye a,, Karl-Jan Spittaels a, Yvonne Achermann b
PMCID: PMC8671523  PMID: 34950868

Abstract

Cutibacterium acnes (previously known as Propionibacterium acnes) is frequently found on lipid-rich parts of the human skin. While C. acnes is most known for its role in the development and progression of the skin disease acne, it is also involved in many other types of infections, often involving implanted medical devices. C. acnes readily forms biofilms in vitro and there is growing evidence that biofilm formation by this Gram-positive, facultative anaerobic micro-organism plays an important role in vivo and is also involved in treatment failure. In this brief review we present an overview on what is known about C. acnes biofilms (including their role in pathogenesis and reduced susceptibility to antibiotics), discuss model systems that can be used to study these biofilms in vitro and in vivo and give an overview of interspecies interactions occurring in polymicrobial communities containing C. acnes.

Keywords: Cutibacterium acnes, Biofilm, Antibiotics

1. Introduction: from the acne bacillus over Propionibacterium acnes to Cutibacterium acnes

Cutibacterium acnes was first described in 1896 as the ‘acne bacillus’ found in comedones of acne patients. It was successfully cultivated in 1897 and formally named Bacillus acnes in 1900. Due to its morphological similarity to members of the genus Corynebacterium, it was reclassified as Corynebacterium acnes in 1923 [1]. Later studies revealed that growth of this organism is inhibited by oxygen and that it produces propionic acid as one of its main fermentation products, and this led to its transfer to the genus Propionibacterium, as Propionibacterium acnes [1]. Propionibacterium spp. were traditionally subdivided in ‘classic’ and ‘cutaneous propionibacteria’. The ‘classic propionibacteria’ contain species isolated from dairy products such as Propionibacterium freudenreichii, while the ‘cutaneous propionibacteria’ comprise P. acnes, Propionibacterium avidum and Propionibacterium granulosum, all isolated from human skin [2]. However, analysis of 16S rRNA gene sequences, and GC content and size of the genomes revealed marked differences between these two groups, and the genus Cutibacterium was proposed for the cutaneous species, resulting in the reclassification of P. acnes as Cutibacterium acnes [3].

Already in 1972 two distinct groups were recognized within this species, based on differences in cell wall composition [4]. Serological agglutination tests allowed subdivision of strains in two serotypes, referred to as type I and II. Type I strains contain glucose, mannose, and galactose as cell wall sugars, whereas galactose is not present in type II strains [4,5]. With the arrival of new techniques, new approaches were developed to group C. acnes isolates and understand C. acnes phylogeny and clonal distribution. A first method was based on the sequences of the tly and the recA genes and allowed further subdivision of serotypes I and II into phylotypes IA1, IA2, IB, IC and II, and, moreover, revealed the additional phylotype III [[6], [7], [8]]. These differences led to the proposal to reclassify the main type I, II and III phylotypes into three distinct subspecies: C. acnes subsp. acnes, C. acnes subsp. defendens, and C. acnes subsp. elongatum for phylotypes I, II and III, respectively [9,10]. Subsequently, two multilocus sequence typing (MLST) schemes have been described for C. acnes. The first is based on the partial sequencing of nine housekeeping genes and was developed in 2010 [11]. A second scheme based on seven genes was developed in 2011 and updated a year later to include eight housekeeping genes [12,13]. More recently, a single locus sequencing typing method has been developed, giving a similar discriminatory power compared to MLST while being cheaper and faster [14]. An alternative approach to grouping C. acnes strains is based on ribotyping. This method is based on sequence analysis of the gene coding for the 16S rRNA [15]. The resulting ribotypes (RT) are based on unique single nucleotide polymorphisms in this gene which allow to distinguish between the main phylotypes as well as between types IA1 and IA2. However, the scheme is not in full agreement with phylotyping, as for example type IB and IC share RT1 and RT5, while RT1 is also shared between type IA1 and IB.

2. Association of C. acnes with the human skin and its role in acne

C. acnes can metabolize lipids produced by the human sebaceous glands, thrives in lipid-rich environments [[16], [17], [18], [19]] and as a result, is most frequently found on the more lipid-rich parts of the human skin including the face, chest, shoulders, and scalp, reaching densities of 106 colony forming units (CFU) per cm2 [[20], [21], [22], [23]]. In contrast, low numbers – approx. 102 CFU per cm2 - are found on dryer areas, such as skin of the lower extremities [22]. Acne is a multifactorial disease of the pilosebaceous unit, and contributing factors include inflammation, changes in keratinization, androgen-induced increase in sebum production and C. acnes colonization of the follicle [24,25]. Excessive production of sebum by the sebaceous gland and hyperkeratinization of the ductal keratinocytes lead to the formation of microcomedones [26]. In these microcomedones, C. acnes thrives in the lipid-rich and anaerobic environment. C. acnes colonization and the resulting activation of the immunocompetent keratinocytes and sebocytes play essential roles in acne pathogenesis. Triglycerides present in the sebum are hydrolyzed by bacterial lipases and the resulting free fatty acids have comedogenic properties and can act as damage associated molecular patterns, while the released glycerol acts as a nutrient source for C. acnes [21]. Other factors produced by C. acnes include co-hemolytic Christie–Atkins–Munch-Peterson (CAMP) factors and porphyrins that will propagate acne pathogenesis through the generation of pro-inflammatory cytokines in human keratinocytes and sebocytes. This includes IL-1β, which is produced as a consequence of activation of the NLRP3 inflammasome [27,28]. Due to the continued sebum production and degradation of the follicular wall as a result of host degrading enzymes, pressure in the pilosebaceous unit increases, which causes the follicle to rupture, releasing all of its contents in adjacent tissue, ultimately leading to formation of superficial pustules, deeper papules or severe nodules [29]. The presence of C. acnes alone is not an explanation for the occurrence of acne, as the organism is present in both healthy and affected hair follicles and it seems equally unlikely that variation in relative abundance of C. acnes can explain the differences observed [15,24]. However, the typing methods mentioned above allow to correlate specific C. acnes groups with disease pathology. C. acnes strains belonging to phylotype IA1 are more often found in acneic skin, while higher phylotypic diversity as well as an enrichment of phylotype II strains can typically be found on healthy skin. In addition, recent research has demonstrated that C. acnes strains belonging to phylotype III dominate in progressive macular hypomelanosis [30,31]. An ‘acne index’ was assigned to each RT by calculating its prevalence in acne patients. As RTs 4, 5, 8, and 10 are significantly enriched on the skin of acne patients, strains belonging to these RTs are characterized by a high acne index. In contrast, RTs 6 and 16 are strongly associated with healthy skin and therefore strains belonging to these RTs possess a low acne index [15,32]. Detailed analysis of the genome sequence of a large number of isolates belonging to these different RTs confirmed the presence of tad and sag genes (involved in adhesion and hemolysis, respectively) in RT4 and RT5, potentially providing a link between the acne index of a C. acnes strains and its virulence properties.

3. Biofilm formation by C. acnes and biofilm composition

Biofilm formation by C. acnes was first described in 1999, when it was shown that C. acnes forms biofilms on prosthetic hips [33]; C. acnes biofilm formation on various biomaterials was subsequently confirmed in a wide range of other studies (e.g. Refs. [[34], [35], [36], [37], [38], [39]]). In 2007 it was shown that several C. acnes strains readily form biofilms in vitro and that production of virulence factors like lipases is increased in biofilms compared to planktonic cells [40]. Upregulation of genes encoding virulence-associated CAMP factors [41] as well as the production of these virulence factors in a sebum-based in vitro biofilm model [42] were subsequently also demonstrated.

The composition of the C. acnes biofilm matrix has been explored in several in vitro studies. Biofilms of a C. acnes skin isolate grown in cell culture flasks contained polysaccharides, proteins and extracellular DNA (eDNA), with the polysaccharides containing α-mannopyranosyl and α-glucopyranosyl residues [41]. The matrix of biofilms of various C. acnes strains recovered from contaminated cardiac pacemaker devices and formed in 96-well plates was found to contain eDNA, proteins, and poly-N-acetyl glucosamine [43]. Finally, biofilms of an acneic C. acnes RT5 strain grown in vitro on cellulose acetate filters were found to contain polysaccharides (62.6%), proteins (9.6%), eDNA (4.0%) and other compounds (23.8%, including porphyrin precursors) [44]. In the latter study the main biofilm matrix polysaccharide was the same as that of the C. acnes cell wall and contained N-acetylgalactosamine, N-acetylmannosamine, 2-acetamido-2-deoxy-galactose and 2,3-di-acetamido-2,3-dideoxy-mannuronic acid residues, but no evidence for the presence of poly-N-acetyl glucosamine was obtained. These data suggest that overall biofilm composition is similar to what is observed in other bacterial biofilms [45] but can vary between strains, environmental conditions and/or biofilm model system. Experiments with proteinase K and DNase I revealed that both enzymes reduce attachment of a variety of C. acnes strains, suggesting that both eDNA and proteins are important for adhesion to abiotic surfaces, although sensitivity to DNase I was more strain-dependent [46].

4. Evidence for C. acnes biofilms in vivo

Jahns, Alexeyev and co-workers [20,47,48] demonstrated the presence of C. acnes biofilm-like structures in acne skin biopsies; such biofilms were more frequently observed in follicles of acne patients than in those of healthy controls [49]. These in vivo C. acnes biofilms showed different morphologies, with some attaching to the follicle wall and/or the hair shaft, while others occurred in the lumen; interestingly these different colonization patterns could be observed in the same hair follicle [48]. C. acnes biofilms were also observed in atherosclerotic carotid artery specimens where they are often part of a multispecies biofilm [50].

However, most evidence for a role of C. acnes in human disease comes from implant-associated infections [24,[51], [52], [53], [54], [55]]. The implementation of improved sampling techniques and diagnostic procedures over the last two decades has led to increased recovery of C. acnes from these infections and there is now convincing evidence that C. acnes biofilms are involved in infections related to the use of prosthetic joints, other orthopedic devices, cerebrovascular devices, breast implants, and cardiovascular devices. In all orthopedic infections, evidence of a biofilm can be found if the fluid from the sonicated implant is investigated [[56], [57], [58], [59]]. Sonication dislodges adherent bacteria off the implant while preserving microbial viability allowing to cultivate biofilm bacteria present in the sonicated fluid [60]. For example, in breast implants it was shown showed that the use of sonication allowed the detection of bacteria in 41% of removed breast implants and positive bacterial culture following sonication of the implant was correlated with the degree of capsular contracture; among the most frequently isolated organisms was C. acnes [37,61]. One of the criteria to confirm a periprosthetic joint infection is recovering the same pathogen in two or more intraoperative cultures, highlighting the importance of culture in diagnosis [62,63]. However, bacteria in the biofilm typically have low metabolic activities and grow slowly, and often conventional culture-based techniques fail to diagnose biofilm-related infections, unless prolonged incubation is used [64,65]. The fact that C. acnes from frozen stocks grows within 2–3 days in a research laboratory but requires up to 14 day to grow from orthopedic infections samples strongly suggests they are present in these samples as biofilms [66]. Among periprosthetic joint infections, C. acnes is the dominant pathogen found after shoulder arthroplasty [24] while Cutibacterium avidum dominates after hip arthroplasty [67]. Treatment includes surgical debridement and antibiotics for a prolonged time. In general, the infection free outcome after treatment of periprosthetic joint infections due to Cutibacterium spp. is about 85%, but worse if only a debridement is performed and the implant is retained [68]. This observation indicates that these infections are biofilm-related and that removal of the periprosthetic biofilm is needed to increase success rate. In a large multicenter study studying risk factors for Cutibacterium spp. relapses, radical surgery and a prolonged antibiotic treatment over 6 weeks led to the best outcomes and avoided relapse of infection [68]. This is yet another indication for the biofilm character of the infection, as a non-biofilm infection would be expected to heal with a shorter antibiotic treatment. C. acnes causes several cardiovascular device-related infections, such as prosthetic valve endocarditis, and pacemaker and cardiac implantable cardioverter-defibrillator infections. Infections can be divided into local infections (pocket infections) or device-related bloodstream infections, including device-related endocarditis [69]. Diagnosis can be challenging because symptoms are often subtle due to low virulence and slow growth of C. acnes. Endocarditis caused by C. acnes has been associated with both native and prosthetic valves but more often develops on valve prostheses, most commonly on the aortic valve [70]. A Swedish national registry of infective endocarditis with a search for Cutibacterium spp. infection between 1995 and 2016 revealed 51 episodes of prosthetic valve endocarditis of which 63% underwent surgery, suggesting a mature biofilm infection that could not be treated with antibiotics alone [71]. The presence of C. acnes biofilms in endocarditis has been confirmed with fluorescent in situ hybridization, which allows confirmation of biofilm-like structures within the histological context and rules out contamination [72]. Spondylodiscitis is an infection of the vertebral body and/or the intervertebral disc space. and is mainly caused by Staphylococcus aureus and Escherichia coli [73]; while infections with C. acnes are rare, they occur. In 2010, Uckay et al. reported 29 patients with spondylodiscitis caused by C. acnes who presented with back pain [74]. In patients with a spinal instrumentation, low-virulent microorganisms such as coagulase-negative staphylococci and C. acnes are typical microorganisms that are identified next to S. aureus or Gram-negative pathogens [75,76]. The biofilm of C. acnes in these cases seems to be an important virulence factor since most of the implant-associated infections requires removal of the implant to cure the infections. For example, Köder et al. found that treatment with biofilm-active antibiotics was associated with better treatment outcome and less postoperative pain intensity although this finding was not specific for C. acnes spine infection [77]. Also in degenerative lumbar disc disease C. acnes can play a role [78], and C. acnes biofilms have been visualized in intervertebral discs of patients undergoing microdiscectomy [79] and in samples from patients with lumbar disc herniation [80].

5. C. acnes biofilms and failure of antimicrobial therapy

Treatment with topical antibiotics (and in the past also systemic antibiotics) is often prescribed in severe cases of acne, and it is thus not a surprise that resistance in C. acnes has emerged worldwide [24,[81], [82], [83]]. While typically a rather sensitive organism, the long courses of antibiotics needed in acne treatment have led to colonization with erythromycin- and clindamycin-resistant strains in >50% of antibiotic-treated patients and >20% of these patients are colonized with tetracycline-resistant strains [84]. As could be expected, resistant C. acnes strains are currently not only found in acne patients treated with antibiotics, but also in other types of infections, including infections related to the use of various medical devices.

It is well-known that microbial biofilm formation contributes to the failure of antimicrobial therapy [85] and failure of antibiotic therapy has partly been attributed to biofilm formation by C. acnes. For example, substantially higher concentrations of cefamandole, ciprofloxacin, and vancomycin are required for inhibition and eradication of in vitro grown C. acnes biofilms (using polymethylmethacrylate bone cement and titanium alloys as substrates) compared to planktonic bacteria [34]. Likewise, compared to planktonic cells, C. acnes biofilms grown in microtiter plates were substantially less sensitive to killing by a range of anti-microbial products used for the treatment of acne, including 0.5% minocycline, 1% clindamycin, 0.5% erythromycin, 0.3% doxycycline, 0.5% oxytetracycline and 2.5–5% benzoyl peroxide [40]. Partial eradication (i.e. reduction to less than 10 CFU/ml) of C. acnes biofilms formed on titanium disks required prolonged exposure to penicillin (7 days), linezolid or linezolid + rifampicin (14 days), and prevention of relapse (i.e. full eradication) required a 14 day treatment of penicillin or linezolid plus rifampicin, but could not be achieved by treatment with linezolid alone [86]. Eradication of C. acnes from glass beads required considerably higher antibiotic concentrations than those needed for killing planktonic cells for rifampicin (4-fold higher), daptomycin (16-fold higher), vancomycin (64-fold higher) and levofloxacin (256-fold higher), while for the β-lactam antibiotics penicillin G and ceftriaxon the difference was smaller (2-fold higher for both) [87]. Finally, it was shown that while penicillin can easily penetrate into in vitro grown C. acnes biofilms, this is not the case for ciprofloxacin and clindamycin, and a four day treatment with the latter antibiotics at a concentration that is 50 times higher than the minimal inhibitory concentration showed no effect [41]. While the studies mentioned above suffer from the limitation that they are in vitro studies using surface-attached biofilms, they clearly indicate that biofilm formation has the potential to contribute to the reduced antimicrobial susceptibility observed for C. acnes in vivo.

6. Interspecies interactions in multispecies communities containing C. acnes

6.1. Interactions of C. acnes with other members of the skin microbiome

The human skin is home to a large number of different bacteria and the skin microbiome plays an important role in controlling colonization by pathogens and in modulating the cutaneous immune system [88,89]. While over 200 genera have been identified on the skin, more than 60% of the genera belong to the corynebacteria, cutibacteria, and staphylococci. Large-scale studies on the microbiome of acneic follicles have not yet been performed, but initial data point to a dominance of Cutibacterium spp., Staphylococcus spp. and Malassezia spp. (previously known as Pityrosporum spp.) [[90], [91], [92]].

Microorganisms colonizing the same skin area influence each other through competition for the limited amount of nutrients on the skin and through the production of antimicrobial compounds [89]. For example, short-chain fatty acids produced by C. acnes inhibit biofilm formation by S. epidermidis and S. aureus (the latter to a lesser extent), but not of Pseudomonas aeruginosa or Bacillus subtilis [93]. In addition, under specific conditions, C. acnes fermentation products inhibit the growth of both S. aureus and S. epidermidis [94]. Finally, the recently described thiopeptide antibiotic cutimycin, produced by C. acnes, reduces colonization of skin hair follicles by Staphylococcus species [95]. These data strongly suggest that C. acnes, while being an important player in the development of acne, also has a beneficial effect on the host, by limiting growth of potential pathogens on the skin.

It should however be noted that these interactions are not a one way street and antagonistic activity of S. epidermidis towards C. acnes has also been described. This could be due to the fermentation of glycerol by S. epidermidis leading to the production of succinic acid or other short chain fatty acids that inhibit C. acnes [96] and/or the secretion of other inhibitory factors, including polymorphic toxins [97]. In addition, it has been suggested that C. acnes biofilms may act as a ‘sanctuary’ for S. aureus, protecting it from harsh conditions during prolonged co-culture [98]. These interactions between S. aureus and C. acnes in polymicrobial communities are definitely not always passive, as it has been shown that S. aureus-induced haemolysis and cell lysis were increased when S. aureus was grown in the presence of C. acnes and that this is due to CAMP factors produced by C. acnes [99]. In addition, coproporhyrin III produced by C. acnes induces S. aureus aggregation and plasma-independent biofilm development on an abiotic surface; this biofilm promoting activity depends on sarA, a known biofilm regulator in S. aureus [100]. Recent work has suggested that these interactions between C. acnes and S. aureus could be co-modulated by human natriuretic peptides [101]. The latter are not the only hormones to which C. acnes responds, as it earlier had been shown that physiologically relevant levels of norepinephrine induce biofilm dispersion and stimulate expression of genes coding for various C. acnes virulence factors (including lipases and hyaluronate lyase) [50].

6.2. Interkingdom interactions between C. acnes and fungi

C. acnes can form multispecies biofilms with the dimorphic fungus Candida albicans [102,103]. Interestingly, unlike pathogens like S. aureus and P. aeruginosa, in these multispecies biofilms C. acnes adheres both to yeast cells and hyphae and the presence of C. acnes in these in vitro biofilms significantly reduced the susceptibility of Candida albicans to the antifungal agent micafungin [102]. Also this interaction seems to be beneficial to both partners, at least under specific conditions, as Candida albicans enhanced early C. acnes biofilm formation in the presence of oxygen (but not in anaerobic conditions) [103]. In the context of development of dandruff, interactions between C. acnes and fungi (in particular species belonging to the genus Malassezia) also appear to be important [104] and mixed-species biofilms of C. acnes and Malassezia restricta were observed in a pre-clinical cell-culture based dandruff model [105]. Currently the molecular basis for the interactions between C. acnes and fungi in these polymicrobial communities is unknown.

7. Model systems to study C. acnes biofilm formation

7.1. In vitro models

While a wide range of in vitro and in vivo biofilm models is available [106,107], most information on C. acnes biofilms is derived from studies in which biofilms are formed on abiotic surfaces (cell culture flask or microtiter plate) under conditions that bear little relevance for the in vivo situation. Recently a dynamic (flow-cell based) model was described as well [108]. Although valuable information about C. acnes biofilm biology can be obtained in these models, it is important to realize that such biofilms are different from in vivo biofilms [109]. To better mimic prosthetic joint infections, in vitro models in which biofilm formation on various biomaterials (including stainless steel and titanium) can be studied, have also been described [34,35,110].

In order to allow the in vitro study of C. acnes biofilms in the context of acne in more in vivo like conditions, a model using artificial sebum (consisting of tripalmitin, palmitic acid, cholesterol, tocopherol acetate, triolein, jojoba oil and squalene, mixed with an equal volume of microbial growth medium) was developed. In this model C. acnes biofilm formation can be studied, as well as the production of virulence factors like lipases, proteases, and CAMP factors [42] (Fig. 1).

Fig. 1.

Fig. 1

Left: Artificial sebum pellet on a silicone support (top) and SYTO-stained C. acnes biofilm model (bottom) [42]. Right: Examples of types of analyses that can be carried out using this model; including antimicrobial susceptibility testing (top) and quantification of production of virulence factors like lipases (middle) and proteases (bottom).

7.2. Cell-culture based models

Several cell-culture based models suitable to study the interaction between C. acnes (biofilms) and the human host are also available. As acne is an exclusively human disease, these models require the use of human cell lines [111,112].

The skin is the first line of defense against external influences and is comprised of immunocompetent cells including keratinocytes, which account for over 95% of all the cells in the epidermis [113]. The most basic form of in vitro keratinocytes are primary normal human epidermal keratinocytes (NHEK), directly dissociated from parental tissue and subsequently grown as monolayers. Although these cells retain the features of the original tissue, the main disadvantage of primary cells is that they will reach senescence after approx. 15–20 passages, limiting the duration and scope of experiments. In contrast, immortalized cell lines can be cultured for an extended time and their genotype and phenotype remains stable over time. These immortalized cell lines can be established after spontaneous mutations or induced by introducing viral oncogenes that affect the cell cycle [113,114]. An example of such a frequently-used cell line is the HaCaT keratinocyte cell line, a spontaneously immortalized cell line derived from a long-term primary culture of skin keratinocytes [115]. The HaCaT cell line exhibits a relative authentic phenotype, is known for its consistent growth and proliferation capacity for over 140 passages, and has been widely used (e.g. Refs. [[116], [117], [118]]). Other immortalized human epidermal keratinocytes include the NM1, NIKS, N/TERT, SV-HEK2, and SVTERT KC cell lines [[119], [120], [121], [122], [123]].

A more complex, tissue-like model is the reconstituted/reconstructed human epidermis (RHE), which requires NHEKs to obtain optimal tissue morphology i.e. a stratified epithelium. In this model, the NHEKs are cultured on a collagen matrix placed at an air-liquid interface, producing 8–12 layers of epidermis, that can be used to study infection and inflammation by various organisms, including C. acnes [105,114,121,124,125]. Some of these RHE models, including EpiDerm, EpiSkin and SkinEthic [[126], [127], [128]] are commercially available. RHE has recently been used to study biofilm formation of C. acnes (alone and in combination with Malassezia restricta) in a pre-clinical dandruff model [105] as well as to study the interaction between acneic skin and different phylotypes of C. acnes [125].

Another important cell type in the context of acne is the sebocyte, and isolation of human sebaceous glands and the culture of primary sebocytes were the first steps in the establishment of an in vitro sebocyte model [129]. However, due to their characteristic terminal differentiation, initiated by the accumulation of lipids until the cells burst, experiments with primary sebocytes are limited in time (3–6 passages) and prolonged experiments thus require multiple donors [112]. In order to overcome this restriction, several immortalized human sebocyte cell lines were developed of which the SZ95 cell line is the most commonly used. Originally obtained from facial sebocytes of a 87-year old woman and transfected with the simian virus-40 large T antigen, SZ95 cells retain the characteristics of normal sebocytes [130]. Other immortalized sebocyte cell lines include SEB-1 [131] and Seb-E6E7 [132].

In order to include the cellular cross-talk between multiple cells of the epidermis, co-culture models have been developed in which two (or more) cell types are combined. Two main types of co-culture models exist; i.e. mixed co-cultures and segregated co-cultures [133]. These models typically result in a more in vivo-like morphology and more realistic environment [134]. One of the most common skin co-culture models uses keratinocytes grown on a dermal compartment containing a collagen matrix and primary normal human dermal fibroblasts [114,135]. Recently an in vitro co-culture model combining HaCaT keratinocytes and SZ95 sebocytes in a ‘well and insert’ system was developed [136,137]. The keratinocytes are cultivated on the membrane at the bottom of the insert, while the sebocytes are grown as monolayers in the well. After cultivation, the keratinocytes in the inserts are infected with C. acnes (Fig. 2). In this model, there is physical contact between keratinocytes and bacteria, whereas indirect interaction, through the production of soluble factors, is possible between the sebocytes in the well and the keratinocytes and bacteria in the insert.

Fig. 2.

Fig. 2

Left: schematic overview of the pilosebaceous unit with the localization of keratinocytes and sebocytes. Right: schematic overview of a C. acnes – keratinocyte – sebocyte co-culture model [136].

Several of the cell-culture based models described above were recently used to elucidate interactions between C. acnes and its human host. First of all, the adhesion of C. acnes cells and biofilm aggregates to HaCaT keratinocytes (Fig. 3) and SZ95 sebocytes, the effect of C. acnes on keratinocyte tight junctions in a HaCaT monoculture and in an keratinocyte-sebocyte co-culture model, and C. acnes invasion through the keratinocyte cell layer, were investigated, and this for a set of phylotype I and II strains [137]. A significantly higher association of (acneic) type I strains to both skin cell lines in comparison to type II strains was observed, and differences in breakdown of tight junctions (higher in type I strains) and invasion frequency (higher in type II strains) were also noted. Secondly, it was shown that acne-associated C. acnes strains and their porphyrin extracts activate NRLP3 inflammasome assembly leading to IL-1β release, something that is not observed in non-acneic strains [136]. These acneic strains were found to produce higher levels of porphyrins than non-acneic strains and this high porphyrin production leads to activation of the inflammasome via the induction of K+ leakage. These observations are in line with previous data showing that acne-associated type I clade IA-2 strains produce significantly higher levels of pro-inflammatory porphyrins than type II strains which are typically associated with healthy skin and contain the porphyrin repressor gene deoR [138]. However, other C. acnes strains that possess deoR (including type I clades IB-3 and IC) also produce high levels of porphyrins [139], indicating other factors must be involved as well. While the biological implications of these observed differences between different C. acnes (sub)groups for the pathogenesis of acne are still unclear, they reinforce the notion that there are profound and biologically-relevant differences between these (sub)groups and illustrate the power of using these cell-culture based models.

Fig. 3.

Fig. 3

C. acnes biofilm aggregates associated with HaCaT cells (stained with a modified Gram stain [137]).

7.3. In vivo models

In order to study C. acnes biofilms under physiologically relevant conditions, several more advanced models have been developed. These include various animal models in which implant-associated infections can be studied, e.g. a foreign-body infection model in which polytetrafluorethylene (Teflon) cages are subcutaneously implanted in the flanks of the guinea pigs [87,140], an intramedullary nail model in rabbits [110], a model for hematogenous infection of a total knee arthroplasty in rabbits [141], a rabbit tibial implant infection model [142] and a sheep intradiscal infection model [143]. The subcutaneous cage model allowed to study the activity of various antibiotics against biofilm-associated C. acnes and demonstrated low cure rates for daptomycin, vancomycin, levofloxacin and rifampicin, despite good activity against planktonic cells. For eradication of these in vivo C. acnes biofilms, combinations of rifampicin with daptomycin (or vancomycin) were required [87]. Use of the rabbit tibial implant infection model led to the identification of 24 immunogenic C. acnes proteins, of which nine were exclusively produced by biofilm-grown C. acnes [142].

Recently a germ-free Drosophila melanogaster (fruit fly) model was developed to study C. acnes, C. avidum and Cutibacterium granulosum biofilms [144]. By maintaining the fruit flies on a lipid-rich diet, an anaerobic lipid-rich environment is created in the gut, which mimics the environment of the hair follicle. Biofilms readily form in this model, which can also be used to study therapeutic interventions (e.g. biofilm dispersal after exposure to DNase I could be demonstrated in this model).

8. Concluding remarks and future perspectives

C. acnes is a skin commensal that is also important in various infections, going from acne to device-related infections. This bacterium contains a wide range of (putative) virulence factors, and biofilm formation seems to be a common theme in many C. acnes infections. There is growing evidence that some C. acnes strains cause more damage to human cells and/or are more pro-inflammatory than others, but why that is the case is not entirely clear. While the increased production of certain virulence factors in biofilm grown C. acnes, as well as differences in the production of virulence factors (e.g. lipase) and pro-inflammatory mediators (e.g. porphyrins) between different C. acnes strains are likely to play a role, more research is needed. In addition, as a skin-associated organism, C. acnes frequently interacts with other organisms and how this influences biofilm formation, virulence, proinflammatory activity and cytotoxicity remains to be investigated in depth.

Declaration of competing interest

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: TOM COENYE is senior editor of Biofilm. Given his role as Senior Editor, TOM COENYE had no involvement in the peer review of this article and has no access to information regarding its peer review. Full responsibility for the editorial process for this article was delegated to AKOS KOVACS.

References

  • 1.Douglas H.C., Gunter S.E. The taxonomic position of Corynebacterium acnes. J Bacteriol. 1946;52:15–23. doi: 10.1128/JB.52.1.15-23.1946. [DOI] [PubMed] [Google Scholar]
  • 2.Stackebrandt E, Cummins CS, Johnson JL. Family propionibacteriaceae: the genus Propionibacterium. The Prokaryotes2006. p. 400-418.
  • 3.Scholz C.F.P., Kilian M. The natural history of cutaneous propionibacteria, and reclassification of selected species within the genus Propionibacterium to the proposed novel genera Acidipropionibacterium gen. nov., Cutibacterium gen. nov. and Pseudopropionibacterium gen. nov. Int J Syst Evol Microbiol. 2016;66:4422–4432. doi: 10.1099/ijsem.0.001367. [DOI] [PubMed] [Google Scholar]
  • 4.Johnson J.L., Cummins C.S. Cell wall composition and deoxyribonucleic acid similarities among the anaerobic coryneforms, classical propionibacteria, and strains of Arachnia propionica. J Bacteriol. 1972;109:1047–1066. doi: 10.1128/jb.109.3.1047-1066.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.McDowell A., Valanne S., Ramage G., Tunney M.M., Glenn J.V., McLorinan G.C., et al. Propionibacterium acnes types I and II represent phylogenetically distinct groups. J Clin Microbiol. 2005;43:326–334. doi: 10.1128/JCM.43.1.326-334.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.McDowell A., Hunyadkurti J., Horvath B., Voros A., Barnard E., Patrick S., et al. Draft genome sequence of an antibiotic-resistant Propionibacterium acnes strain, PRP-38, from the novel type IC cluster. J Bacteriol. 2012;194:3260–3261. doi: 10.1128/JB.00479-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Kwon H.H., Yoon J.Y., Park S.Y., Suh D.H. Analysis of distribution patterns ofPropionibacterium acnesphylotypes andPeptostreptococcusspecies from acne lesions. Br J Dermatol. 2013;169:1152–1155. doi: 10.1111/bjd.12486. [DOI] [PubMed] [Google Scholar]
  • 8.Shannon B.A., Cohen R.J., Garrett K.L. Polymerase chain reaction-based identification of Propionibacterium acnes types isolated from the male urinary tract: evaluation of adolescents, normal adults and men with prostatic pathology. BJU Int. 2006;98:388–392. doi: 10.1111/j.1464-410X.2006.06273.x. [DOI] [PubMed] [Google Scholar]
  • 9.McDowell A., Barnard E., Liu J., Li H., Patrick S. Emendation of Propionibacterium acnes subsp. acnes (Deiko et al. 2015) and proposal of Propionibacterium acnes type II as Propionibacterium acnes subsp. defendens subsp. nov. Int J Syst Evol Microbiol. 2016;66:5358–5365. doi: 10.1099/ijsem.0.001521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Dekio I., Culak R., Misra R., Gaulton T., Fang M., Sakamoto M., et al. Dissecting the taxonomic heterogeneity within Propionibacterium acnes: proposal for Propionibacterium acnes subsp. acnes subsp. nov. and Propionibacterium acnes subsp. elongatum subsp. nov. Int J Syst Evol Microbiol. 2015;65:4776–4787. doi: 10.1099/ijsem.0.000648. [DOI] [PubMed] [Google Scholar]
  • 11.Lomholt H.B., Kilian M. Population genetic analysis of Propionibacterium acnes identifies a subpopulation and epidemic clones associated with acne. PLoS One. 2010;5 doi: 10.1371/journal.pone.0012277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.McDowell A., Gao A., Barnard E., Fink C., Murray P.I., Dowson C.G., et al. A novel multilocus sequence typing scheme for the opportunistic pathogen Propionibacterium acnes and characterization of type I cell surface-associated antigens. Microbiology. 2011;157:1990–2003. doi: 10.1099/mic.0.049676-0. [DOI] [PubMed] [Google Scholar]
  • 13.McDowell A., Barnard E., Nagy I., Gao A., Tomida S., Li H., et al. An expanded multilocus sequence typing scheme for propionibacterium acnes: investigation of 'pathogenic', 'commensal' and antibiotic resistant strains. PLoS One. 2012;7 doi: 10.1371/journal.pone.0041480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Scholz C.F., Jensen A., Lomholt H.B., Bruggemann H., Kilian M. A novel high-resolution single locus sequence typing scheme for mixed populations of Propionibacterium acnes in vivo. PLoS One. 2014;9 doi: 10.1371/journal.pone.0104199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Fitz-Gibbon S., Tomida S., Chiu B.H., Nguyen L., Du C., Liu M., et al. Propionibacterium acnes strain populations in the human skin microbiome associated with acne. J Invest Dermatol. 2013;133:2152–2160. doi: 10.1038/jid.2013.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Wójcik A., Budzisz E., Rotsztejn H. Review paper Skin surface lipids and their measurements. Adv Dermatol Allergol/Post?py Dermatologii i Alergologii. 2011;28:498–505. [Google Scholar]
  • 17.Reisner R.M., Silver D.Z., Puhvel M., Sternberg T.H. Lipolytic activity of Corynebacterium acnes. J Invest Dermatol. 1968;51:190–196. [PubMed] [Google Scholar]
  • 18.Gribbon E.M., Cunliffe W.J., Holland K.T. Interaction of Propionibacterium acnes with skin lipids in vitro. J Gen Microbiol. 1993;139:1745–1751. doi: 10.1099/00221287-139-8-1745. [DOI] [PubMed] [Google Scholar]
  • 19.Rebillo T., Hawk J.L. Skin surface glycerol levels in acne vulgaris. J Invest Dermatol. 1978;70:352–354. doi: 10.1111/1523-1747.ep12543549. [DOI] [PubMed] [Google Scholar]
  • 20.Jahns A.C., Eilers H., Ganceviciene R., Alexeyev O.A. Propionibacterium species and follicular keratinocyte activation in acneic and normal skin. Br J Dermatol. 2015;172:981–987. doi: 10.1111/bjd.13436. [DOI] [PubMed] [Google Scholar]
  • 21.Josse G., Mias C., Le Digabel J., Filiol J., Ipinazar C., Villaret A., et al. High bacterial colonization and lipase activity in microcomedones. Exp Dermatol. 2020;29:168–176. doi: 10.1111/exd.14069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Leyden J.J., McGinley K.J., Vowels B. Propionibacterium acnes colonization in acne and nonacne. Dermatology. 1998;196:55–58. doi: 10.1159/000017868. [DOI] [PubMed] [Google Scholar]
  • 23.Zhang N., Yuan R., Xin K.Z., Lu Z., Ma Y. Antimicrobial susceptibility, biotypes and phylotypes of clinical Cutibacterium (formerly propionibacterium) acnes strains isolated from acne patients: an observational study. Dermatol Ther. 2019;9:735–746. doi: 10.1007/s13555-019-00320-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Achermann Y., Goldstein E.J., Coenye T., Shirtliff M.E. Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen. Clin Microbiol Rev. 2014;27:419–440. doi: 10.1128/CMR.00092-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Zouboulis CC, Katsambas AD, Kligman AM. Pathogenesis and treatment of acne and Rosacea2014.
  • 26.Cunliffe W.J., Holland D.B., Clark S.M., Stables G.I. Comedogenesis: some new aetiological, clinical and therapeutic strategies. Br J Dermatol. 2000;142:1084–1091. doi: 10.1046/j.1365-2133.2000.03531.x. [DOI] [PubMed] [Google Scholar]
  • 27.Nagy I., Pivarcsi A., Kis K., Koreck A., Bodai L., McDowell A., et al. Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microb Infect. 2006;8:2195–2205. doi: 10.1016/j.micinf.2006.04.001. [DOI] [PubMed] [Google Scholar]
  • 28.Li Z.J., Choi D.K., Sohn K.C., Seo M.S., Lee H.E., Lee Y., et al. Propionibacterium acnes activates the NLRP3 inflammasome in human sebocytes. J Invest Dermatol. 2014;134:2747–2756. doi: 10.1038/jid.2014.221. [DOI] [PubMed] [Google Scholar]
  • 29.Moradi Tuchayi S., Makrantonaki E., Ganceviciene R., Dessinioti C., Feldman S.R., Zouboulis C.C. Acne vulgaris. Nature reviews Disease primers. 2015;1:15029. doi: 10.1038/nrdp.2015.29. [DOI] [PubMed] [Google Scholar]
  • 30.Barnard E., Liu J., Yankova E., Cavalcanti S.M., Magalhaes M., Li H., et al. Strains of the Propionibacterium acnes type III lineage are associated with the skin condition progressive macular hypomelanosis. Sci Rep. 2016;6:31968. doi: 10.1038/srep31968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Petersen R.L., Scholz C.F., Jensen A., Bruggemann H., Lomholt H.B. Propionibacterium acnes phylogenetic type III is associated with progressive macular hypomelanosis. Eur. J. Microbiol. Immunol. 2017;7:37–45. doi: 10.1556/1886.2016.00040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Tomida S., Nguyen L., Chiu B.H., Liu J., Sodergren E., Weinstock G.M., et al. Pan-genome and comparative genome analyses of propionibacterium acnes reveal its genomic diversity in the healthy and diseased human skin microbiome. mBio. 2013;4:e00003–13. doi: 10.1128/mBio.00003-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Tunney M.M., Patrick S., Curran M.D., Ramage G., Hanna D., Nixon J.R., et al. Detection of prosthetic hip infection at revision arthroplasty by immunofluorescence microscopy and PCR amplification of the bacterial 16S rRNA gene. J Clin Microbiol. 1999;37:3281–3290. doi: 10.1128/jcm.37.10.3281-3290.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Ramage G., Tunney M.M., Patrick S., Gorman S.P., Nixon J.R. Formation of Propionibacterium acnes biofilms on orthopaedic biomaterials and their susceptibility to antimicrobials. Biomaterials. 2003;24:3221–3227. doi: 10.1016/s0142-9612(03)00173-x. [DOI] [PubMed] [Google Scholar]
  • 35.Bayston R., Ashraf W., Barker-Davies R., Tucker E., Clement R., Clayton J., et al. Biofilm formation by Propionibacterium acnes on biomaterials in vitro and in vivo: impact on diagnosis and treatment. J Biomed Mater Res. 2007;81:705–709. doi: 10.1002/jbm.a.31145. [DOI] [PubMed] [Google Scholar]
  • 36.Rieger U.M., Mesina J., Kalbermatten D.F., Haug M., Frey H.P., Pico R., et al. Bacterial biofilms and capsular contracture in patients with breast implants. Br J Surg. 2013;100:768–774. doi: 10.1002/bjs.9084. [DOI] [PubMed] [Google Scholar]
  • 37.Rieger U.M., Raschke G.F., Frei R., Djedovic G., Pierer G., Trampuz A. Role of bacterial biofilms in patients after reconstructive and aesthetic breast implant surgery. J Long Term Eff Med Implants. 2014;24:131–138. doi: 10.1615/jlongtermeffmedimplants.2014011206. [DOI] [PubMed] [Google Scholar]
  • 38.Rieger U.M., Djedovic G., Pattiss A., Raschke G.F., Frei R., Pierer G., et al. Presence of biofilms on polyurethane-coated breast implants: preliminary results. J Long Term Eff Med Implants. 2016;26:237–243. doi: 10.1615/JLongTermEffMedImplants.2016016851. [DOI] [PubMed] [Google Scholar]
  • 39.Garcia D., Mayfield C.K., Leong J., Deckey D.G., Zega A., Glasser J., et al. Early adherence and biofilm formation of Cutibacterium acnes (formerly Propionibacterium acnes) on spinal implant materials. Spine J : Off. J. North Am. Spine Soc. 2020;20:981–987. doi: 10.1016/j.spinee.2020.01.001. [DOI] [PubMed] [Google Scholar]
  • 40.Coenye T., Peeters E., Nelis H.J. Biofilm formation by Propionibacterium acnes is associated with increased resistance to antimicrobial agents and increased production of putative virulence factors. Res Microbiol. 2007;158:386–392. doi: 10.1016/j.resmic.2007.02.001. [DOI] [PubMed] [Google Scholar]
  • 41.Jahns A.C., Eilers H., Alexeyev O.A. Transcriptomic analysis of Propionibacterium acnes biofilms in vitro. Anaerobe. 2016;42:111–118. doi: 10.1016/j.anaerobe.2016.10.001. [DOI] [PubMed] [Google Scholar]
  • 42.Spittaels K.J., Coenye T. Developing an in vitro artificial sebum model to study Propionibacterium acnes biofilms. Anaerobe. 2018;49:21–29. doi: 10.1016/j.anaerobe.2017.11.002. [DOI] [PubMed] [Google Scholar]
  • 43.Okuda K.I., Nagahori R., Yamada S., Sugimoto S., Sato C., Sato M., et al. The composition and structure of biofilms developed by propionibacterium acnes isolated from cardiac pacemaker devices. Front Microbiol. 2018;9:182. doi: 10.3389/fmicb.2018.00182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Gannesen A.V., Zdorovenko E.L., Botchkova E.A., Hardouin J., Massier S., Kopitsyn D.S., et al. Composition of the biofilm matrix of Cutibacterium acnes acneic strain RT5. Front Microbiol. 2019;10:1284. doi: 10.3389/fmicb.2019.01284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Flemming H.C., Wingender J. The biofilm matrix. Nat Rev Microbiol. 2010;8:623–633. doi: 10.1038/nrmicro2415. [DOI] [PubMed] [Google Scholar]
  • 46.Kuehnast T., Cakar F., Weinhaupl T., Pilz A., Selak S., Schmidt M.A., et al. Comparative analyses of biofilm formation among different Cutibacterium acnes isolates. Int. J. Med. Microbiol. : IJMM. 2018;308:1027–1035. doi: 10.1016/j.ijmm.2018.09.005. [DOI] [PubMed] [Google Scholar]
  • 47.Alexeyev O.A., Jahns A.C. Sampling and detection of skin Propionibacterium acnes: current status. Anaerobe. 2012;18:479–483. doi: 10.1016/j.anaerobe.2012.07.001. [DOI] [PubMed] [Google Scholar]
  • 48.Jahns A.C., Alexeyev O.A. Three dimensional distribution of Propionibacterium acnes biofilms in human skin. Exp Dermatol. 2014;23:687–689. doi: 10.1111/exd.12482. [DOI] [PubMed] [Google Scholar]
  • 49.Jahns A.C., Lundskog B., Ganceviciene R., Palmer R.H., Golovleva I., Zouboulis C.C., et al. An increased incidence of Propionibacterium acnes biofilms in acne vulgaris: a case-control study. Br J Dermatol. 2012;167:50–58. doi: 10.1111/j.1365-2133.2012.10897.x. [DOI] [PubMed] [Google Scholar]
  • 50.Lanter B.B., Davies D.G. Propionibacterium acnes recovered from atherosclerotic human carotid arteries undergoes biofilm dispersion and releases lipolytic and proteolytic enzymes in response to norepinephrine challenge in vitro. Infect Immun. 2015;83:3960–3971. doi: 10.1128/IAI.00510-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Lin Z.X., Steed L.L., Marculescu C.E., Slone H.S., Woolf S.K. Cutibacterium acnes infection in orthopedics: microbiology, clinical findings, diagnostic strategies, and management. Orthopedics. 2020;43:52–61. doi: 10.3928/01477447-20191213-02. [DOI] [PubMed] [Google Scholar]
  • 52.Boisrenoult P. Cutibacterium acnes prosthetic joint infection: diagnosis and treatment. Orthopaed. Traumatol. Surg. Res. : OTSR. 2018;104:S19–S24. doi: 10.1016/j.otsr.2017.05.030. [DOI] [PubMed] [Google Scholar]
  • 53.Gharamti A.A., Kanafani Z.A. Cutibacterium (formerly Propionibacterium) acnes infections associated with implantable devices. Expert Rev Anti-infect Ther. 2017;15:1083–1094. doi: 10.1080/14787210.2017.1404452. [DOI] [PubMed] [Google Scholar]
  • 54.Aubin G.G., Portillo M.E., Trampuz A., Corvec S. Propionibacterium acnes, an emerging pathogen: from acne to implant-infections, from phylotype to resistance. Med Maladies Infect. 2014;44:241–250. doi: 10.1016/j.medmal.2014.02.004. [DOI] [PubMed] [Google Scholar]
  • 55.Portillo M.E., Corvec S., Borens O., Trampuz A. Propionibacterium acnes: an underestimated pathogen in implant-associated infections. BioMed Res Int. 2013;2013:804391. doi: 10.1155/2013/804391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Akgun D., Maziak N., Plachel F., Siegert P., Minkus M., Thiele K., et al. The role of implant sonication in the diagnosis of periprosthetic shoulder infection. J Shoulder Elbow Surg. 2020;29:e222–e228. doi: 10.1016/j.jse.2019.10.011. [DOI] [PubMed] [Google Scholar]
  • 57.Jeverica S., El Sayed F., Camernik P., Kocjancic B., Sluga B., Rottman M., et al. Growth detection of Cutibacterium acnes from orthopaedic implant-associated infections in anaerobic bottles from BACTEC and BacT/ALERT blood culture systems and comparison with conventional culture media. Anaerobe. 2020;61:102133. doi: 10.1016/j.anaerobe.2019.102133. [DOI] [PubMed] [Google Scholar]
  • 58.Burger J., Akgun D., Strube P., Putzier M., Pumberger M. Sonication of removed implants improves microbiological diagnosis of postoperative spinal infections. Eur Spine J : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society. 2019;28:768–774. doi: 10.1007/s00586-019-05881-x. [DOI] [PubMed] [Google Scholar]
  • 59.Reischies F.M.J., Krause R., Holzer J., Tiefenbacher F., Winter R., Eylert G., et al. What can we learn from sonication results of breast implants? PLoS One. 2017;12 doi: 10.1371/journal.pone.0182267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Trampuz A., Piper K.E., Jacobson M.J., Hanssen A.D., Unni K.K., Osmon D.R., et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med. 2007;357:654–663. doi: 10.1056/NEJMoa061588. [DOI] [PubMed] [Google Scholar]
  • 61.Rieger U.M., Pierer G., Luscher N.J., Trampuz A. Sonication of removed breast implants for improved detection of subclinical infection. Aesthetic Plast Surg. 2009;33:404–408. doi: 10.1007/s00266-009-9333-0. [DOI] [PubMed] [Google Scholar]
  • 62.McNally M., Sousa R., Wouthuyzen-Bakker M., Chen A.F., Soriano A., Vogely H.C., et al. The EBJIS definition of periprosthetic joint infection. Bone Joint J. 2021;103-B:18–25. doi: 10.1302/0301-620X.103B1.BJJ-2020-2417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.McNally M., Sousa R., Wouthuyzen-Bakker M., Chen A.F., Soriano A., Vogely H.C., et al. Infographic: the EBJIS definition of periprosthetic joint infection. Bone Joint J. 2021;103-B:16–17. doi: 10.1302/0301-620X.103B1.BJJ-2020-2417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Vulin C., Leimer N., Huemer M., Ackermann M., Zinkernagel A.S. Prolonged bacterial lag time results in small colony variants that represent a sub-population of persisters. Nat Commun. 2018;9:4074. doi: 10.1038/s41467-018-06527-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Hoiby N., Bjarnsholt T., Moser C., Bassi G.L., Coenye T., Donelli G., et al. ESCMID guideline for the diagnosis and treatment of biofilm infections 2014. Clin. Microbiol. Infect. : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2015;21(Suppl 1):S1–S25. doi: 10.1016/j.cmi.2014.10.024. [DOI] [PubMed] [Google Scholar]
  • 66.Schafer P., Fink B., Sandow D., Margull A., Berger I., Frommelt L. Prolonged bacterial culture to identify late periprosthetic joint infection: a promising strategy. Clin Infect Dis : Off. Publ. Infect. Dis. Soc. Am. 2008;47:1403–1409. doi: 10.1086/592973. [DOI] [PubMed] [Google Scholar]
  • 67.Achermann Y., Liu J., Zbinden R., Zingg P.O., Anagnostopoulos A., Barnard E., et al. Propionibacterium avidum: a virulent pathogen causing hip periprosthetic joint infection. Clin Infect Dis : Off. Publ. Infect. Dis. Soc. Am. 2018;66:54–63. doi: 10.1093/cid/cix665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Kusejko K., Aunon A., Jost B., Natividad B., Strahm C., Thurnheer C., et al. The impact of surgical strategy and rifampin on treatment outcome in Cutibacterium periprosthetic joint infections. Clin Infect Dis : Off. Publ. Infect. Dis. Soc. Am. 2021;72:e1064–e1073. doi: 10.1093/cid/ciaa1839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Sohail M.R., Gray A.L., Baddour L.M., Tleyjeh I.M., Virk A. Infective endocarditis due to Propionibacterium species. Clin. Microbiol. Infect. : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2009;15:387–394. doi: 10.1111/j.1469-0691.2009.02703.x. [DOI] [PubMed] [Google Scholar]
  • 70.Delahaye F., Fol S., Celard M., Vandenesch F., Beaune J., Bozio A., et al. [Propionibacterium acnes infective endocarditis. Study of 11 cases and review of literature] Arch Mal Coeur Vaiss. 2005;98:1212–1218. [PubMed] [Google Scholar]
  • 71.Lindell F., Soderquist B., Sundman K., Olaison L., Kallman J. Prosthetic valve endocarditis caused by Propionibacterium species: a national registry-based study of 51 Swedish cases. Eur J Clin Microbiol Infect Dis : Off. Publ. Eur. Soc. Clin. Microbiol. 2018;37:765–771. doi: 10.1007/s10096-017-3172-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Xu Y., Larsen L.H., Lorenzen J., Hall-Stoodley L., Kikhney J., Moter A., et al. Microbiological diagnosis of device-related biofilm infections. APMIS : Acta Pathologica Microbiologica Et Immunologica Scandinavica. 2017;125:289–303. doi: 10.1111/apm.12676. [DOI] [PubMed] [Google Scholar]
  • 73.Stangenberg M., Mende K.C., Mohme M., Kratzig T., Viezens L., Both A., et al. Influence of microbiological diagnosis on the clinical course of spondylodiscitis. Infection. 2021;49:1017–1027. doi: 10.1007/s15010-021-01642-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Uckay I., Dinh A., Vauthey L., Asseray N., Passuti N., Rottman M., et al. Spondylodiscitis due to Propionibacterium acnes: report of twenty-nine cases and a review of the literature. Clin. Microbiol. Infect. : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2010;16:353–358. doi: 10.1111/j.1469-0691.2009.02801.x. [DOI] [PubMed] [Google Scholar]
  • 75.Sampedro M.F., Huddleston P.M., Piper K.E., Karau M.J., Dekutoski M.B., Yaszemski M.J., et al. A biofilm approach to detect bacteria on removed spinal implants. Spine. 2010;35:1218–1224. doi: 10.1097/BRS.0b013e3181c3b2f3. [DOI] [PubMed] [Google Scholar]
  • 76.Margaryan D., Renz N., Bervar M., Zahn R., Onken J., Putzier M., et al. Spinal implant-associated infections: a prospective multicentre cohort study. Int J Antimicrob Agents. 2020;56:106116. doi: 10.1016/j.ijantimicag.2020.106116. [DOI] [PubMed] [Google Scholar]
  • 77.Koder K., Hardt S., Gellert M.S., Haupenthal J., Renz N., Putzier M., et al. Outcome of spinal implant-associated infections treated with or without biofilm-active antibiotics: results from a 10-year cohort study. Infection. 2020;48:559–568. doi: 10.1007/s15010-020-01435-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Capoor M.N., Birkenmaier C., Wang J.C., McDowell A., Ahmed F.S., Bruggemann H., et al. A review of microscopy-based evidence for the association of Propionibacterium acnes biofilms in degenerative disc disease and other diseased human tissue. Eur Spine J : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society. 2019;28:2951–2971. doi: 10.1007/s00586-019-06086-y. [DOI] [PubMed] [Google Scholar]
  • 79.Capoor M.N., Ruzicka F., Schmitz J.E., James G.A., Machackova T., Jancalek R., et al. Propionibacterium acnes biofilm is present in intervertebral discs of patients undergoing microdiscectomy. PLoS One. 2017;12 doi: 10.1371/journal.pone.0174518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Ohrt-Nissen S., Fritz B.G., Walbom J., Kragh K.N., Bjarnsholt T., Dahl B., et al. Bacterial biofilms: a possible mechanism for chronic infection in patients with lumbar disc herniation - a prospective proof-of-concept study using fluorescence in situ hybridization. Acta Pathologica Microbiologica Et Immunologica Scandinavica. 2018;126:440–447. doi: 10.1111/apm.12841. [DOI] [PubMed] [Google Scholar]
  • 81.Nord C.E., Oprica C. Antibiotic resistance in Propionibacterium acnes. Microbiological and clinical aspects. Anaerobe. 2006;12:207–210. doi: 10.1016/j.anaerobe.2006.08.001. [DOI] [PubMed] [Google Scholar]
  • 82.Dessinioti C., Katsambas A. Propionibacterium acnes and antimicrobial resistance in acne. Clin Dermatol. 2017;35:163–167. doi: 10.1016/j.clindermatol.2016.10.008. [DOI] [PubMed] [Google Scholar]
  • 83.Aslan Kayiran M., Karadag A.S., Al-Khuzaei S., Chen W., Parish L.C. Antibiotic resistance in acne: mechanisms, complications and management. Am J Clin Dermatol. 2020;21:813–819. doi: 10.1007/s40257-020-00556-6. [DOI] [PubMed] [Google Scholar]
  • 84.Walsh T.R., Efthimiou J., Dreno B. Systematic review of antibiotic resistance in acne: an increasing topical and oral threat. Lancet Infect Dis. 2016;16:e23–33. doi: 10.1016/S1473-3099(15)00527-7. [DOI] [PubMed] [Google Scholar]
  • 85.Van Acker H., Van Dijck P., Coenye T. Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms. Trends Microbiol. 2014;22:326–333. doi: 10.1016/j.tim.2014.02.001. [DOI] [PubMed] [Google Scholar]
  • 86.Bayston R., Nuradeen B., Ashraf W., Freeman B.J. Antibiotics for the eradication of Propionibacterium acnes biofilms in surgical infection. J Antimicrob Chemother. 2007;60:1298–1301. doi: 10.1093/jac/dkm408. [DOI] [PubMed] [Google Scholar]
  • 87.Furustrand Tafin U., Corvec S., Betrisey B., Zimmerli W., Trampuz A. Role of rifampin against Propionibacterium acnes biofilm in vitro and in an experimental foreign-body infection model. Antimicrob Agents Chemother. 2012;56:1885–1891. doi: 10.1128/AAC.05552-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Belkaid Y., Segre J.A. Dialogue between skin microbiota and immunity. Science. 2014;346:954–959. doi: 10.1126/science.1260144. [DOI] [PubMed] [Google Scholar]
  • 89.Byrd A.L., Belkaid Y., Segre J.A. The human skin microbiome. Nat Rev Microbiol. 2018;16:143–155. doi: 10.1038/nrmicro.2017.157. [DOI] [PubMed] [Google Scholar]
  • 90.Akaza N., Akamatsu H., Numata S., Yamada S., Yagami A., Nakata S., et al. Microorganisms inhabiting follicular contents of facial acne are not only Propionibacterium but also Malassezia spp. J Dermatol. 2016;43:906–911. doi: 10.1111/1346-8138.13245. [DOI] [PubMed] [Google Scholar]
  • 91.Findley K., Grice E.A. The skin microbiome: a focus on pathogens and their association with skin disease. PLoS Pathog. 2014;10 doi: 10.1371/journal.ppat.1004436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Xu H., Li H. Acne, the skin microbiome, and antibiotic treatment. Am J Clin Dermatol. 2019;20:335–344. doi: 10.1007/s40257-018-00417-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Nakamura K., O'Neill A.M., Williams M.R., Cau L., Nakatsuji T., Horswill A.R., et al. Short chain fatty acids produced by Cutibacterium acnes inhibit biofilm formation by Staphylococcus epidermidis. Sci Rep. 2020;10:21237. doi: 10.1038/s41598-020-77790-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Francuzik W., Franke K., Schumann R.R., Heine G., Worm M. Propionibacterium acnes abundance correlates inversely with Staphylococcus aureus: data from atopic dermatitis skin microbiome. Acta Derm Venereol. 2018;98:490–495. doi: 10.2340/00015555-2896. [DOI] [PubMed] [Google Scholar]
  • 95.Claesen J., Spagnolo J.B., Ramos S.F., Kurita K.L., Byrd A.L., Aksenov A.A., et al. A Cutibacterium acnes antibiotic modulates human skin microbiota composition in hair follicles. Sci Transl Med. 2020;12 doi: 10.1126/scitranslmed.aay5445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Wang Y., Kuo S., Shu M., Yu J., Huang S., Dai A., et al. Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: implications of probiotics in acne vulgaris. Appl Microbiol Biotechnol. 2014;98:411–424. doi: 10.1007/s00253-013-5394-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Christensen G.J., Scholz C.F., Enghild J., Rohde H., Kilian M., Thurmer A., et al. Antagonism between Staphylococcus epidermidis and Propionibacterium acnes and its genomic basis. BMC Genom. 2016;17:152. doi: 10.1186/s12864-016-2489-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Tyner H., Patel R. Propionibacterium acnes biofilm - a sanctuary for Staphylococcus aureus? Anaerobe. 2016;40:63–67. doi: 10.1016/j.anaerobe.2016.05.014. [DOI] [PubMed] [Google Scholar]
  • 99.Lo C.W., Lai Y.K., Liu Y.T., Gallo R.L., Huang C.M. Staphylococcus aureus hijacks a skin commensal to intensify its virulence: immunization targeting beta-hemolysin and CAMP factor. J Invest Dermatol. 2011;131:401–409. doi: 10.1038/jid.2010.319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Wollenberg M.S., Claesen J., Escapa I.F., Aldridge K.L., Fischbach M.A., Lemon K.P. Propionibacterium-produced coproporphyrin III induces Staphylococcus aureus aggregation and biofilm formation. mBio. 2014;5:e01286–14. doi: 10.1128/mBio.01286-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Gannesen A.V., Lesouhaitier O., Racine P.J., Barreau M., Netrusov A.I., Plakunov V.K., et al. Regulation of monospecies and mixed biofilms formation of skin Staphylococcus aureus and Cutibacterium acnes by human natriuretic peptides. Front Microbiol. 2018;9:2912. doi: 10.3389/fmicb.2018.02912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Bernard C., Renaudeau N., Mollichella M.L., Quellard N., Girardot M., Imbert C. Cutibacterium acnes protects Candida albicans from the effect of micafungin in biofilms. Int J Antimicrob Agents. 2018;52:942–946. doi: 10.1016/j.ijantimicag.2018.08.009. [DOI] [PubMed] [Google Scholar]
  • 103.Bernard C., Lemoine V., Hoogenkamp M.A., Girardot M., Krom B.P., Imbert C. Candida albicans enhances initial biofilm growth of Cutibacterium acnes under aerobic conditions. Biofouling. 2019;35:350–360. doi: 10.1080/08927014.2019.1608966. [DOI] [PubMed] [Google Scholar]
  • 104.Clavaud C., Jourdain R., Bar-Hen A., Tichit M., Bouchier C., Pouradier F., et al. Dandruff is associated with disequilibrium in the proportion of the major bacterial and fungal populations colonizing the scalp. PLoS One. 2013;8 doi: 10.1371/journal.pone.0058203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Meloni M., Balzaretti S., Collard N., Desaint S., Laperdrix C. Reproducing the scalp microbiota community: co-colonization of a 3D reconstructed human epidermis with C. acnes and M. restricta. Int J Cosmet Sci. 2021;43:235–245. doi: 10.1111/ics.12688. [DOI] [PubMed] [Google Scholar]
  • 106.Coenye T., Nelis H.J. In vitro and in vivo model systems to study microbial biofilm formation. J Microbiol Methods. 2010;83:89–105. doi: 10.1016/j.mimet.2010.08.018. [DOI] [PubMed] [Google Scholar]
  • 107.Azeredo J., Azevedo N.F., Briandet R., Cerca N., Coenye T., Costa A.R., et al. Critical review on biofilm methods. Crit Rev Microbiol. 2017;43:313–351. doi: 10.1080/1040841X.2016.1208146. [DOI] [PubMed] [Google Scholar]
  • 108.Varin-Simon J., Lamret F., Colin M., Gangloff S.C., Mongaret C., Reffuveille F. Comparison of two Cutibacterium acnes biofilm models. Microorganisms. 2021;9 doi: 10.3390/microorganisms9102035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Bjarnsholt T., Alhede M., Alhede M., Eickhardt-Sorensen S.R., Moser C., Kuhl M., et al. The in vivo biofilm. Trends Microbiol. 2013;21:466–474. doi: 10.1016/j.tim.2013.06.002. [DOI] [PubMed] [Google Scholar]
  • 110.Gahukamble A.D., McDowell A., Post V., Salavarrieta Varela J., Rochford E.T., Richards R.G., et al. Propionibacterium acnes and Staphylococcus lugdunensis cause pyogenic osteomyelitis in an intramedullary nail model in rabbits. J Clin Microbiol. 2014;52:1595–1606. doi: 10.1128/JCM.03197-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111.Zouboulis C.C., Xia L., Akamatsu H., Seltmann H., Fritsch M., Hornemann S., et al. The human sebocyte culture model provides new insights into development and management of seborrhoea and acne. Dermatology. 1998;196:21–31. doi: 10.1159/000017861. [DOI] [PubMed] [Google Scholar]
  • 112.Xia L., Zouboulis C.C., Ju Q. Culture of human sebocytes in vitro. Derm Endocrinol. 2009;1:92–95. doi: 10.4161/derm.1.2.8736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113.Choi M., Lee C. Immortalization of primary keratinocytes and its application to skin research. Biomol. Therapeut. 2015;23:391–399. doi: 10.4062/biomolther.2015.038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.Hutter V, Kirton SB, Chau DYS. Immunocompetent human in vitro skin models. Skin tissue models for regenerative Medicine2018. p. 353-373.
  • 115.Boukamp P., Petrussevska R.T., Breitkreutz D., Hornung J., Markham A., Fusenig N.E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol. 1988;106:761–771. doi: 10.1083/jcb.106.3.761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 116.Deyrieux A.F., Wilson V.G. In vitro culture conditions to study keratinocyte differentiation using the HaCaT cell line. Cytotechnology. 2007;54:77–83. doi: 10.1007/s10616-007-9076-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 117.Grange P.A., Raingeaud J., Calvez V., Dupin N. Nicotinamide inhibits Propionibacterium acnes-induced IL-8 production in keratinocytes through the NF-kappaB and MAPK pathways. J Dermatol Sci. 2009;56:106–112. doi: 10.1016/j.jdermsci.2009.08.001. [DOI] [PubMed] [Google Scholar]
  • 118.Ottaviani M., Alestas T., Flori E., Mastrofrancesco A., Zouboulis C.C., Picardo M. Peroxidated squalene induces the production of inflammatory mediators in HaCaT keratinocytes: a possible role in acne vulgaris. J Invest Dermatol. 2006;126:2430–2437. doi: 10.1038/sj.jid.5700434. [DOI] [PubMed] [Google Scholar]
  • 119.Baden H.P., Kubilus J., Kvedar J.C., Steinberg M.L., Wolman S.R. Isolation and characterization of a spontaneously arising long-lived line of human keratinocytes (NM 1). In vitro cellular & developmental biology. J. Tissue Culture Assoc. 1987;23:205–213. doi: 10.1007/BF02623581. [DOI] [PubMed] [Google Scholar]
  • 120.Allen-Hoffmann B.L., Schlosser S.J., Ivarie C.A., Sattler C.A., Meisner L.F., O'Connor S.L. Normal growth and differentiation in a spontaneously immortalized near-diploid human keratinocyte cell line, NIKS. J Invest Dermatol. 2000;114:444–455. doi: 10.1046/j.1523-1747.2000.00869.x. [DOI] [PubMed] [Google Scholar]
  • 121.Smits J.P.H., Niehues H., Rikken G., van Vlijmen-Willems I., van de Zande G., Zeeuwen P., et al. Immortalized N/TERT keratinocytes as an alternative cell source in 3D human epidermal models. Sci Rep. 2017;7:11838. doi: 10.1038/s41598-017-12041-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122.Kim C.W., Kim C.D., Choi K.C. Establishment and evaluation of immortalized human epidermal keratinocytes for an alternative skin irritation test. J Pharmacol Toxicol Methods. 2017;88:130–139. doi: 10.1016/j.vascn.2017.08.005. [DOI] [PubMed] [Google Scholar]
  • 123.Wagner T., Gschwandtner M., Strajeriu A., Elbe-Burger A., Grillari J., Grillari-Voglauer R., et al. Establishment of keratinocyte cell lines from human hair follicles. Sci Rep. 2018;8:13434. doi: 10.1038/s41598-018-31829-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124.Faway E., Lambert de Rouvroit C., Poumay Y. In vitro models of dermatophyte infection to investigate epidermal barrier alterations. Exp Dermatol. 2018;27:915–922. doi: 10.1111/exd.13726. [DOI] [PubMed] [Google Scholar]
  • 125.Laclaverie M., Rouaud-Tinguely P., Grimaldi C., Juge R., Marchand L., Aymard E., et al. Development and characterization of a 3D in vitro model mimicking acneic skin. Exp Dermatol. 2021;30:347–357. doi: 10.1111/exd.14268. [DOI] [PubMed] [Google Scholar]
  • 126.Netzlaff F., Lehr C.M., Wertz P.W., Schaefer U.F. The human epidermis models EpiSkin, SkinEthic and EpiDerm: an evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance transport. Eur J Pharm Biopharm : Off. J. Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik Ev. 2005;60:167–178. doi: 10.1016/j.ejpb.2005.03.004. [DOI] [PubMed] [Google Scholar]
  • 127.Pedrosa A.F., Lisboa C., Branco J., Almeida A.C., Mendes C., Pellevoisin C., et al. Malassezia colonisation on a reconstructed human epidermis: imaging studies. Mycoses. 2019;62:1194–1201. doi: 10.1111/myc.13011. [DOI] [PubMed] [Google Scholar]
  • 128.Nailis H., Kucharikova S., Ricicova M., Van Dijck P., Deforce D., Nelis H., et al. Real-time PCR expression profiling of genes encoding potential virulence factors in Candida albicans biofilms: identification of model-dependent and -independent gene expression. BMC Microbiol. 2010;10:114. doi: 10.1186/1471-2180-10-114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 129.Xia L.Q., Zouboulis C., Detmar M., Mayer-da-Silva A., Stadler R., Orfanos C.E. Isolation of human sebaceous glands and cultivation of sebaceous gland-derived cells as an in vitro model. J Invest Dermatol. 1989;93:315–321. [PubMed] [Google Scholar]
  • 130.Zouboulis C.C., Seltmann H., Neitzel H., Orfanos C.E. Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95) J Invest Dermatol. 1999;113:1011–1020. doi: 10.1046/j.1523-1747.1999.00771.x. [DOI] [PubMed] [Google Scholar]
  • 131.Thiboutot D., Jabara S., McAllister J.M., Sivarajah A., Gilliland K., Cong Z., et al. Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1) J Invest Dermatol. 2003;120:905–914. doi: 10.1046/j.1523-1747.2003.12244.x. [DOI] [PubMed] [Google Scholar]
  • 132.Lo Celso C., Berta M.A., Braun K.M., Frye M., Lyle S., Zouboulis C.C., et al. Characterization of bipotential epidermal progenitors derived from human sebaceous gland: contrasting roles of c-Myc and beta-catenin. Stem Cells (Dayton) 2008;26:1241–1252. doi: 10.1634/stemcells.2007-0651. [DOI] [PubMed] [Google Scholar]
  • 133.Thelu A., Catoire S., Kerdine-Romer S. Immune-competent in vitro co-culture models as an approach for skin sensitisation assessment. Toxicol Vitro : Int. J. Publ. Assoc. BIBRA. 2020;62:104691. doi: 10.1016/j.tiv.2019.104691. [DOI] [PubMed] [Google Scholar]
  • 134.Vidmar J., Chingwaru C., Chingwaru W. Mammalian cell models to advance our understanding of wound healing: a review. J Surg Res. 2017;210:269–280. doi: 10.1016/j.jss.2016.10.016. [DOI] [PubMed] [Google Scholar]
  • 135.Holland D.B., Bojar R.A., Jeremy A.H., Ingham E., Holland K.T. Microbial colonization of an in vitro model of a tissue engineered human skin equivalent--a novel approach. FEMS Microbiol Lett. 2008;279:110–115. doi: 10.1111/j.1574-6968.2007.01021.x. [DOI] [PubMed] [Google Scholar]
  • 136.Spittaels K.-J., van Uytfanghe K., Zouboulis C.C., Stove C., Crabbé A., Coenye T. Porphyrins produced by acneic Cutibacterium acnes strains activate the inflammasome by inducing K+ leakage. iScience. 2021;24 doi: 10.1016/j.isci.2021.102575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 137.Spittaels K.J., Ongena R., Zouboulis C.C., Crabbe A., Coenye T. Cutibacterium acnes phylotype I and II strains interact differently with human skin cells. Front. Cell. Infect. Microbiol. 2020;10:575164. doi: 10.3389/fcimb.2020.575164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 138.Johnson T., Kang D., Barnard E., Li H. Strain-level differences in porphyrin production and regulation in propionibacterium acnes elucidate disease associations. mSphere. 2016;1 doi: 10.1128/mSphere.00023-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 139.Barnard E., Johnson T., Ngo T., Arora U., Leuterio G., McDowell A., et al. Porphyrin production and regulation in cutaneous propionibacteria. mSphere. 2020;5 doi: 10.1128/mSphere.00793-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 140.Zimmerli W., Waldvogel F.A., Vaudaux P., Nydegger U.E. Pathogenesis of foreign body infection: description and characteristics of an animal model. J Infect Dis. 1982;146:487–497. doi: 10.1093/infdis/146.4.487. [DOI] [PubMed] [Google Scholar]
  • 141.Blomgren G., Lundquist H., Nord C.E., Lindgren U. Late anaerobic haematogenous infection of experimental total joint replacement. A study in the rabbit using Propionibacterium acnes. J. Bone Joint Surg. British. 1981;63B:614–618. doi: 10.1302/0301-620X.63B4.7298696. [DOI] [PubMed] [Google Scholar]
  • 142.Achermann Y., Tran B., Kang M., Harro J.M., Shirtliff M.E. Immunoproteomic identification of in vivo-produced propionibacterium acnes proteins in a rabbit biofilm infection model. Clin Vaccine Immunol : CVI. 2015;22:467–476. doi: 10.1128/CVI.00760-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 143.Coscia E.C., Abutaleb N.S., Hostetter B., Seleem M.N., Breur G.J., McCain R.R., et al. Sheep as a potential model of intradiscal infection by the bacterium Cutibacterium acnes. Veterinary sciences. 2021;8 doi: 10.3390/vetsci8030048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 144.Bronnec V., Alexeyev O.A. In vivo model of Propionibacterium (Cutibacterium) spp. biofilm in Drosophila melanogaster. Anaerobe. 2021;72:102450. doi: 10.1016/j.anaerobe.2021.102450. [DOI] [PubMed] [Google Scholar]

Articles from Biofilm are provided here courtesy of Elsevier

RESOURCES